Similarly, Li (Li et al., 2021) revealed that HIF-2α transcriptally suppresses CPT-1 expression and prevents NLPR3 inflammasome activation, ultimately alleviating insulin resistance in chronic metabolic diseases. This evidence concerns the gene EPAS1 and Insulin resistance.